IRADIMED CORP 10-K

ITEM 5. MARKET FOR REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES Market for Common Stock Our common stock has been publicly traded on the Nasdaq Capital Market under the stock symbol “IRMD” since July 16, 2014. Prior to that date, there was no public market for our common stock. The stock market in general has experienced significant stock price fluctuations in the past few years. In some cases, these fluctuations have been unrelated to the operating performance of the affected companies. Therefore, many companies have experienced dramatic volatility in the market prices of their common stock. We believe that a number of factors, both within and outside our control, could cause the price of our common stock to fluctuate, perhaps substantially. Factors such as the following (and others) could have a significant adverse impact on the market price of our common stock: ● Our financial position and results of operations; ● Our ability, if needed, to obtain additional financing and, if available, the terms and conditions of the financing; ● Concern as to, or other evidence of, the reliability and efficiency of our proposed products or our competitors’ products; ● Announcements of innovations or new products by us or our competitors; ● Federal, state, and international governmental regulatory actions and the impact of such requirements on our business; ● The development of litigation against us; ● Period-to-period fluctuations in our operating results; ● Changes in estimates of our performance by any securities analysts; ● The issuance of new equity securities pursuant to a future offering or acquisition; ● Poorly executed acquisitions or acquisitions whose projected potential is not realized; ● Changes in interest rates; ● Competitive developments, including announcements by competitors of new products or significant contracts, acquisitions, strategic partnerships, joint ventures or capital commitments; ● Sales of large blocks of our stock; ● Investor perceptions of our company; and ● General economic and other national and international conditions. Stockholders As of February 28, 2023, we had 3 stockholders of record. This number is significantly less than and does not include “street name” or beneficial holders, whose shares are held by banks, brokers, financial institutions and other nominees. 41 Table of Contents Dividends On February 2, 2023, the Board of Directors declared a special cash dividend of $1.05 per share on the Company’s common stock, paid on February 21, 2023 to shareholders of record at the close of business on February 13, 2023. The decision on whether to pay cash dividends on our common stock in the future will be made by our board of directors, at its discretion, and will depend on our financial condition, operating results, capital requirements and other factors that the board of directors considers significant. Unregistered Sales of Securities; Use of Proceeds from Registered Securities None. Purchases of Equity Securities by the Issuer The following table provides information regarding repurchases of common stock for the year ended December 31, 2022. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total Number Maximum ​ ​ ​ ​ ​ ​ ​ of Shares ​ Dollar Value of ​ ​ ​ ​ ​ ​ ​ Purchased as ​ Shares that ​ ​ Total ​ ​ ​ ​ Part of ​ May Yet ​ ​ Number of ​ ​ ​ ​ Publicly ​ Be Purchased ​ ​ Shares ​ Average Price ​ Announced ​ Under the ​ ​ Purchased ​ Paid per Share ​ Plans or ​ Plans or ​ ​ (1) ​ (2) ​ Programs ​ Programs January 1, 2022—January 31, 2022 1,095 ​ $ — — ​ $ — February 1, 2022—February 28, 2022 48 ​ $ — — ​ $ — March 1, 2022—March 31, 2022 458 ​ $ — — ​ $ — April 1, 2022—April 30, 2022 47 ​ $ — — ​ $ — May 1, 2022—May 31, 2022 75 ​ $ — — ​ $ — June 1, 2022—June 30, 2022 41 ​ $ — — ​ $ — July 1, 2022—July 31, 2022 567 ​ $ — — ​ $ — August 1, 2022—August 31, 2022 16 ​ $ — — ​ $ — September 1, 2022—September 30,2022 52 ​ $ — — ​ $ — October 1, 2022—October 31, 2022 333 ​ $ — — ​ $ — November 1, 2022—November 30, 2022 — ​ $ — — ​ $ — December 1, 2022—December 31, 2022 6,612 ​ $ — — ​ $ — Total 9,344 ​ $ — — ​ $ — (1) The number of shares purchased reflects shares withheld for taxes on vesting of restricted stock. There were no shares repurchased pursuant to the open market repurchase authorization. (2) The average price paid per share does not include the withheld shares discussed in (1). Transfer Agent The transfer agent and registrar for our common stock is Broadridge Financial Solutions, Inc. Equity Compensation Plan Information Our equity compensation plan information is provided as set forth in Part III, Item 11 herein. 42 Table of Contents Additional Information Copies of our annual reports, quarterly reports, current reports, and any amendments to those reports, are available free of charge on the Internet at www.sec.gov. All statements made in any of our filings, including all forward-looking statements, are made as of the date of the document, in which the statement is included, and we do not assume or undertake any obligation to update any of those statements or documents unless we are required to do so by law. Stock Performance Graph The following information of Part II Item 5 is being furnished and shall not be deemed to be “soliciting material” or to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor will it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that we specifically incorporate such information by reference thereto. The following graph shows a comparison, from December 31, 2017 through December 31, 2022, of cumulative total return for our common stock, the Russell 2000 Index and the Nasdaq Medical Equipment Index. Such returns are based on historical results and are not intended to suggest future performance. Data for the Russell 2000 Index and the Nasdaq Medical Equipment Index assumes reinvestment of dividends. ​ ​ 43 Table of Contents ITEM 6. [RESERVED] ​ ​